Free Trial

Inspire Medical Systems (INSP) Competitors

Inspire Medical Systems logo
$184.88 +8.82 (+5.01%)
(As of 11/20/2024 ET)

INSP vs. SOLV, SNN, PEN, GKOS, BLCO, PRCT, AXNX, NVST, NARI, and LIVN

Should you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), PROCEPT BioRobotics (PRCT), Axonics (AXNX), Envista (NVST), Inari Medical (NARI), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry.

Inspire Medical Systems vs.

Solventum (NYSE:SOLV) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, community ranking, institutional ownership and dividends.

94.9% of Inspire Medical Systems shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Solventum currently has a consensus target price of $68.00, indicating a potential downside of 0.57%. Inspire Medical Systems has a consensus target price of $233.58, indicating a potential upside of 26.35%. Given Inspire Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe Inspire Medical Systems is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solventum
1 Sell rating(s)
8 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Inspire Medical Systems
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75

Inspire Medical Systems has a net margin of 4.37% compared to Solventum's net margin of 0.00%. Inspire Medical Systems' return on equity of 5.30% beat Solventum's return on equity.

Company Net Margins Return on Equity Return on Assets
SolventumN/A N/A N/A
Inspire Medical Systems 4.37%5.30%4.58%

Inspire Medical Systems received 186 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 61.31% of users gave Inspire Medical Systems an outperform vote while only 5.88% of users gave Solventum an outperform vote.

CompanyUnderperformOutperform
SolventumOutperform Votes
1
5.88%
Underperform Votes
16
94.12%
Inspire Medical SystemsOutperform Votes
187
61.31%
Underperform Votes
118
38.69%

Solventum has higher earnings, but lower revenue than Inspire Medical Systems.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SolventumN/AN/AN/AN/AN/A
Inspire Medical Systems$624.80M8.87-$21.15M$1.07172.78

In the previous week, Solventum had 2 more articles in the media than Inspire Medical Systems. MarketBeat recorded 15 mentions for Solventum and 13 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.29 beat Solventum's score of 0.88 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solventum
9 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspire Medical Systems
9 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Inspire Medical Systems beats Solventum on 12 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INSP vs. The Competition

MetricInspire Medical SystemsSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$5.54B$4.41B$5.03B$19.87B
Dividend YieldN/A41.16%5.16%3.52%
P/E Ratio172.7824.82135.4142.95
Price / Sales8.8747.021,160.9719.16
Price / CashN/A51.8733.5317.86
Price / Book9.534.974.675.52
Net Income-$21.15M$13.76M$119.07M$986.45M
7 Day Performance6.91%-1.08%-1.83%0.45%
1 Month Performance-9.08%0.58%-3.60%1.05%
1 Year Performance34.11%50.91%31.66%24.67%

Inspire Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INSP
Inspire Medical Systems
4.91 of 5 stars
$184.88
+5.0%
$233.58
+26.3%
+29.2%$5.28B$624.80M172.781,011Analyst Upgrade
Positive News
Gap Up
SOLV
Solventum
1.804 of 5 stars
$68.39
+2.0%
$68.00
-0.6%
N/A$11.58BN/A0.0022,000
SNN
Smith & Nephew
2.1198 of 5 stars
$25.22
-1.2%
N/A-1.4%$11.15B$5.55B0.0018,452
PEN
Penumbra
4.3167 of 5 stars
$239.20
+0.9%
$227.92
-4.7%
+1.6%$9.18B$1.16B278.144,200Analyst Forecast
Insider Trade
GKOS
Glaukos
3.8428 of 5 stars
$141.44
-1.9%
$134.55
-4.9%
+121.3%$7.80B$360.35M-46.83780Positive News
BLCO
Bausch + Lomb
2.7887 of 5 stars
$19.39
-0.8%
$20.91
+7.8%
+23.2%$6.88B$4.15B0.0013,300
PRCT
PROCEPT BioRobotics
1.5867 of 5 stars
$92.70
-0.9%
$89.50
-3.5%
+180.7%$4.88B$136.19M0.00626
AXNX
Axonics
3.2587 of 5 stars
$70.98
flat
$71.00
+0.0%
N/A$3.63B$366.38M-591.45610News Coverage
NVST
Envista
3.6426 of 5 stars
$20.37
+0.5%
$20.71
+1.7%
-14.3%$3.49B$2.57B-2.6212,800
NARI
Inari Medical
3.255 of 5 stars
$49.00
-3.9%
$58.89
+20.2%
-15.9%$2.98B$493.63M0.001,300Insider Trade
Positive News
LIVN
LivaNova
4.1794 of 5 stars
$50.05
-2.6%
$69.17
+38.2%
+6.8%$2.79B$1.15B119.172,900

Related Companies and Tools


This page (NYSE:INSP) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners